HAART – The best treatment modality for widespread and disfigured giant molluscum contagiosum


  • Masuma P Bhengra
  • Aniket Bhole
  • Prabhat Kumar
  • Shyam Sundar Chaudhary


Molluscum contagiosum, highly active antiretroviral (HAART) therapy


Molluscum contagiosum (MC) is a common viral infection caused by molluscum contagiosum virus (MCV), a double-stranded DNA virus which belongs to Poxviridae family. It is frequently seen in young children and sexually active adults. The transmission of spread occurs both by sexual and nonsexual routes like direct contact with infected skin, mucous membrane or via fomites. The incubation period varies from two to six months. In immunocompetent persons, the molluscum lesions typically appear as painless, flesh-colored or skin-coloured, dome shaped papules of size 2-3mm with central umbilication that can appear anywhere on the body, but most often located on the face, neck and intertriginous sites like axilla and popliteal fossa. However, atypical forms (giant, verrucous, agminate forms) with involvement of genitalia are more common in immune – compromised persons particularly in sexually active adults. It is usually self-limited in immunocompetent individuals while in HIV-infected patients with advance disease, the lesions are more widespread and extensive. Due to its longer period of persistence and poor response to conventional therapies, the clinicians often face difficulties to treat it. Several reports document that variety of treatment options had been tried for widespread molluscum contagiosum but none had been considered to be the ideal and standard treatment. Herein, we report a case of 6-year-old HIV-infected boy with multiple, tumour like nodules (agminate variety); a rare presentation of molluscum contagiosum over face and other body parts which successfully resolved with exclusive HAART therapy.


Kumar P, Chatura KR, Jagannath VK et al. Giant molluscum contagiosum in an infant. Indian J Dermatol Venereol Leprol. 1999;65:290-1.

Laxmisha C, Thappa DM, Jaisankar TJ. Clinical profile of molluscum contagiosum in children versus adults. Dermatol Online J. 2003;9:1.

Koopman RJ, van Merrilnboer FC, Vreden SG, Dolmans WM. Molluscum contagiosum a marker for advanced HIV infection. Br J Dermatol. 1992;126:528-9.

Czelusta A, Yen-Moore A, Van der Straten M et al. An overview of sexually transmitted diseases: Part III, Sexually transmitted diseases in HIV infected patients. J Am Acad Dermatol. 2000;43:409-32.

World Health Organization. (WHO) 2000a. Adaptation of the IMCI guidelines to take into account a high prevalence of HIV infection among children. Draft report of a consultative meeting in Durban, South Africa: August 16-18, 2000.

Lynch PJ, Minkin W. Molluscum contagiosum of the adult: Probable venereal transmission. Arch Dermatol. 1968;98:141- 3.

Vozmediano JM, Manriquk A, Petraglia S et al. Giant molluscum contagiosum in AIDS. Int J Dermatol. 1996;35:45-7.

Zancanaro PC, McGirt LY, Mamelak AJ et al. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol. 2006;54:581-8.

Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection: A review of twenty seven patients. J Am Acad Dermatol. 1992;27:583-8.

Van der Wouden JC, Menke J, Gajadin S et al. Intervention for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2006;2:CD004767.

Cronin TA, Resnik BI, Elgart G et al. Recalcitrant giant molluscum contagiosum in patient with AIDS. J Am Acad Dermatol. 1996;35:266-7.

Reynaud-Mendel B, Janier M, Gerbaka J et al. Dermatologic findings in HIV-1-infected patients: a prospective study with emphasis on CC4+ cell count. Dermatology. 1996;192:325-8.

Calista D, Boschini A, Landi G. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS. Eur J Dermatol. 1999;9:211-3.

Cattelan AM, Sasset L, Corti L et al. A complete remission of recalcitrant molluscum contagiosum in an AIDS patient following highly active antiretroviral therapy (HAART). J Infect. 1999;38:58-60.